or
forgot password

The Huntsman Cancer Institute - The Use of Microarray Analysis in Characterizing Mesenchymal Tissue Tumors: Differentiation of Normal, Benign, and Malignant Conditions


N/A
N/A
N/A
Open (Enrolling)
Both
Soft Tissue Sarcoma, Osteosarcoma

Thank you

Trial Information

The Huntsman Cancer Institute - The Use of Microarray Analysis in Characterizing Mesenchymal Tissue Tumors: Differentiation of Normal, Benign, and Malignant Conditions


as stated in brief summary


Inclusion Criteria:



- Bone or soft tissue tumor that has been established to be or is suspected to possibly
be a sarcoma AND who will require a diagnostic or therapeutic surgical procedure
which will result in procurement of tissue for histologic review

Exclusion Criteria:

- Non cancer patients

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Outcome Measure:

Classification of sarcomas

Outcome Description:

sarcomas will be classified by researchers at Huntsman Institute

Outcome Time Frame:

Upon collection/analysis of sarcoma

Safety Issue:

No

Principal Investigator

Timothy A Damron, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

State University of New York - Upstate Medical University

Authority:

United States: Institutional Review Board

Study ID:

Huntsman Cancer Institute

NCT ID:

NCT00615329

Start Date:

April 2003

Completion Date:

December 2015

Related Keywords:

  • Soft Tissue Sarcoma
  • Osteosarcoma
  • Create tumor specific gene profiles to improve diagnostic accuracy
  • Perform gene set validation for diagnostic predictive power
  • Define deviant gene list implicated in pathogenesis
  • Osteosarcoma
  • Sarcoma

Name

Location
SUNY Upstate Medical University Syracuse, New York  13210